Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00172029
Status:
COMPLETED
Last Update Posted:
2023-08-18
First Post:
2005-09-13
Brief Title:
Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid
Sponsor:
Novartis
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CZOL446ETR01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
External Affairs
Old Organization:
Novartis Pharmaceuticals